Matthew Heisler

Matthew Heisler has extensive experience in the biotechnology field, currently serving as the Associate Director of Ligand Development at Repligen Corporation since January 2021. Prior to this role, Matthew held positions at Repligen Corporation as a Senior Scientist from January 2016 to January 2021 and as a Research Associate from January 2013 to January 2016. Early career experiences include serving as a Research Assistant at Repligen Corporation, a Research Technician at the University of North Carolina at Chapel Hill, as well as various roles during academic tenure at Northeastern University, including Student in Biochemistry and Research Assistant. Matthew earned a Bachelor’s Degree in Biochemistry and a Master’s Degree in Biotechnology from Northeastern University, completing the latter in 2019.